LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Home・Aktien・Alcon Inc

Alcon Inc

Geschlossen

BrancheGesundheitswesen

66.57 3.5

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

64.21

Max

66.58

Schlüsselkennzahlen
By Trading Economics
Einkommen	-32M 185M
Verkäufe	-65M 2.7B
KGV Branchendurchschnitt	39.341 49.888
EPS	0.85
Dividendenrendite	0.55
Gewinnspanne	6.984
Angestellte	25,000
EBITDA	168M 689M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+34.72% upside

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	0.55% 2.38%
Nächstes Ergebnis	10. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-4.7B 32B
Vorheriger Eröffnungskurs	63.07
Vorheriger Schlusskurs	66.57

Nachrichtenstimmung

By Acuity

26%

74%

59 / 344 Ranking in Healthcare

Alcon Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. März 2026, 14:42 UTC

Wichtige Markttreiber

Akquisitionen, Fusionen, Übernahmen

Lensar Share Slide on Terminated Merger Deal With Alcon

16. März 2026, 21:37 UTC

Akquisitionen, Fusionen, Übernahmen

Lensar and Alcon Agree to Terminate Merger

6. Jan. 2026, 15:11 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9. Dez. 2025, 18:51 UTC

Akquisitionen, Fusionen, Übernahmen

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9. Dez. 2025, 15:54 UTC

Wichtige Markttreiber

Akquisitionen, Fusionen, Übernahmen

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9. Dez. 2025, 14:32 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon Upgrades Offer Price for Staar Surgical

5. Mai 2026, 21:25 UTC

Ergebnisse

Alcon Inc. 1Q EPS 39c >ALC.EB

5. Mai 2026, 21:25 UTC

Ergebnisse

Alcon Inc. 1Q Rev $2.71B >ALC.EB

16. März 2026, 20:59 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16. März 2026, 20:59 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16. März 2026, 20:59 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16. März 2026, 20:57 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

25. Feb. 2026, 22:29 UTC

Akquisitionen, Fusionen, Übernahmen

Lensar Expects to Close Transaction in 1H of 2026 >LNSR

25. Feb. 2026, 22:29 UTC

Akquisitionen, Fusionen, Übernahmen

Lensar, Alcon Continue to Cooperate With FTC in Connection With Request for Additional Info >LNSR

25. Feb. 2026, 22:28 UTC

Akquisitionen, Fusionen, Übernahmen

LENSAR Provides Update on Pending Acquisition by Alcon

24. Feb. 2026, 21:41 UTC

Ergebnisse

Alcon 4Q Rev $2.72B >ALC.EB

7. Jan. 2026, 01:00 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6. Jan. 2026, 22:03 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6. Jan. 2026, 22:03 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6. Jan. 2026, 15:21 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6. Jan. 2026, 14:56 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6. Jan. 2026, 14:14 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6. Jan. 2026, 14:14 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6. Jan. 2026, 14:14 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6. Jan. 2026, 14:13 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9. Dez. 2025, 14:17 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon Ups Offer Price for Staar Surgical

9. Dez. 2025, 13:34 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9. Dez. 2025, 13:33 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9. Dez. 2025, 13:33 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9. Dez. 2025, 13:33 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

Peer-Vergleich

Kursveränderung

Alcon Inc Prognose

Kursziel

By TipRanks

34.72% Vorteil

12-Monats-Prognose

Durchschnitt 86.52 USD 34.72%

Hoch 108.762 USD

Tief 63.234 USD

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Alcon Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

12 ratings

Buy

Halten

Sell

Basierend auf 12 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Alcon Inc – Dist abgegeben haben.

Stimmung

By Acuity

59 / 344 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.